Headquartered in Sarasota, Florida, Roper Technologies, Inc. (ROP - Free Report) designs, manufactures and distributes medical and scientific imaging products and software, radio frequency (RF) products, services and application software, industrial technology products and energy systems and controls products and solutions.
Roper Technologies caters to selected segments of a broad range of markets, which include oil & gas, scientific research, medical diagnostics, semiconductor, refrigeration, automotive, water & wastewater, power generation, agricultural irrigation and other niche industries.
However, the company is significantly exposed to cyclical slowdown in markets like Energy and Industrial. Sluggish macroeconomic growth is a concern for the company, as it lowers infrastructure spending, which negatively impacts Roper’s overall growth.
Zacks Rank: Currently, Roper Technologies has a Zacks Rank#3 (Hold) but that could change following its second quarter 2017 earnings report which has just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We have highlighted some of the key details from the just-released announcement below:
Earnings: Roper reported adjusted earnings per share of $2.24 beating the Zacks Consensus Estimate of $2.22. The company expects third quarter earnings in the band of $2.24 - $2.30. For 2017, the company expects adjusted earnings per share in a range of $9.12–$9.30, compared with $8.98–$9.28 per share.
Revenue: Revenues of $1.135 billion were up 21.8% year over year but missed the Zacks Consensus Estimate of $1.156 billion.
Key Stats: Adjusted gross margin increased 170 bps to 62.7% in the quarter.
Check back later for our full write up on this ROP earnings report later!
More Stock News: 8 Companies Verge on Apple-Like RunDid you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>